<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id>
      <journal-title-group>
        <journal-title>BMC Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2377</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22023810</article-id>
      <article-id pub-id-type="pmc">3217914</article-id>
      <article-id pub-id-type="publisher-id">1471-2377-11-131</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2377-11-131</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Parkinsonian phenotype in Machado-Joseph disease (MJD/SCA3): a two-case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" id="A1">
          <name>
            <surname>Bettencourt</surname>
            <given-names>Concei&#xE7;&#xE3;o</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <xref ref-type="aff" rid="I4">4</xref>
          <email>mcbettencourt@uac.pt</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Santos</surname>
            <given-names>Cristina</given-names>
          </name>
          <xref ref-type="aff" rid="I5">5</xref>
          <email>Cristina.Santos@uab.es</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Coutinho</surname>
            <given-names>Paula</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <xref ref-type="aff" rid="I6">6</xref>
          <email>Paula.Coutinho@hospitalfeira.min-saude.pt</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Rizzu</surname>
            <given-names>Patrizia</given-names>
          </name>
          <xref ref-type="aff" rid="I7">7</xref>
          <email>P.Rizzu@vumc.nl</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Vasconcelos</surname>
            <given-names>Jo&#xE3;o</given-names>
          </name>
          <xref ref-type="aff" rid="I8">8</xref>
          <email>neurazor@hdes.pt</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Kay</surname>
            <given-names>Teresa</given-names>
          </name>
          <xref ref-type="aff" rid="I9">9</xref>
          <email>teresakay8@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Cymbron</surname>
            <given-names>Teresa</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>tcymbron@uac.pt</email>
        </contrib>
        <contrib contrib-type="author" id="A8">
          <name>
            <surname>Raposo</surname>
            <given-names>Mafalda</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>msraposo@uac.pt</email>
        </contrib>
        <contrib contrib-type="author" id="A9">
          <name>
            <surname>Heutink</surname>
            <given-names>Peter</given-names>
          </name>
          <xref ref-type="aff" rid="I7">7</xref>
          <email>P.Heutink@vumc.nl</email>
        </contrib>
        <contrib contrib-type="author" id="A10">
          <name>
            <surname>Lima</surname>
            <given-names>Manuela</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>mlima@uac.pt</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Center of Research in Natural Resources (CIRN), University of the Azores, Ponta Delgada, Portugal</aff>
      <aff id="I2"><label>2</label>Department of Biology, University of the Azores, Ponta Delgada, Portugal</aff>
      <aff id="I3"><label>3</label>Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal</aff>
      <aff id="I4"><label>4</label>Laboratorio de Biolog&#xED;a Molecular, Instituto de Enfermedades Neurol&#xF3;gicas, Fundaci&#xF3;n Socio-Sanitaria de Castilla-La Mancha, Guadalajara, Spain</aff>
      <aff id="I5"><label>5</label>Unitat Antropologia Biol&#xF2;gica, Dep. Biologia Animal, Biologia Vegetal i Ecologia, Universitat Aut&#xF2;noma de Barcelona, Bellaterra (Barcelona), Spain</aff>
      <aff id="I6"><label>6</label>Department of Neurology, Hospital S&#xE3;o Sebasti&#xE3;o, Feira, Portugal</aff>
      <aff id="I7"><label>7</label>Section of Medical Genomics, Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands</aff>
      <aff id="I8"><label>8</label>Department of Neurology, Hospital of Divino Espirito Santo, Ponta Delgada, Portugal</aff>
      <aff id="I9"><label>9</label>Department of Clinical Genetics, Hospital of D. Estefania, Lisbon, Portugal</aff>
      <pub-date pub-type="collection">
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>10</month>
        <year>2011</year>
      </pub-date>
      <volume>11</volume>
      <fpage>131</fpage>
      <lpage>131</lpage>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>5</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>10</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9;2011 Bettencourt et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Bettencourt et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1471-2377/11/131"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Machado-Joseph disease (MJD), or spinocerebellar ataxia type 3 (SCA3), is an autosomal dominant neurodegenerative disorder of late onset, which is caused by a CAG repeat expansion in the coding region of the <italic>ATXN3 </italic>gene. This disease presents clinical heterogeneity, which cannot be completely explained by the size of the repeat tract. MJD presents extrapyramidal motor signs, namely Parkinsonism, more frequently than the other subtypes of autosomal dominant cerebellar ataxias. Although Parkinsonism seems to segregate within MJD families, only a few MJD patients develop parkinsonian features and, therefore, the clinical and genetic aspects of these rare presentations remain poorly investigated. The main goal of this work was to describe two MJD patients displaying the parkinsonian triad (tremor, bradykinesia and rigidity), namely on what concerns genetic variation in Parkinson's disease (PD) associated loci (<italic>PARK2, LRRK2, PINK1, DJ-1, SNCA, MAPT, APOE</italic>, and mtDNA <italic>tRNA</italic><sup><italic>Gln </italic></sup>T4336C). </p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>Patient 1 is a 40 year-old female (onset at 30 years of age), initially with a pure parkinsonian phenotype (similar to the phenotype previously reported for her mother). Patient 2 is a 38 year-old male (onset at 33 years of age), presenting an ataxic phenotype with parkinsonian features (not seen either in other affected siblings or in his father). Both patients presented an expanded <italic>ATXN3 </italic>allele with 72 CAG repeats. No PD mutations were found in the analyzed loci. However, allelic variants previously associated with PD were observed in <italic>DJ-1 </italic>and <italic>APOE </italic>genes, for both patients.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The present report adds clinical and genetic information on this particular and rare MJD presentation, and raises the hypothesis that <italic>DJ-1 </italic>and <italic>APOE </italic>polymorphisms may confer susceptibility to the parkinsonian phenotype in MJD.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Autosomal dominant cerebellar ataxias (ADCA) constitute a heterogeneous group of neurodegenerative disorders, which involve, besides other systems, the extrapyramidal system in a highly variable manner. Within this group is Machado-Joseph disease (MJD; MIM #109150), also known as spinocerebellar ataxia type 3 (SCA3), that presents extrapyramidal motor signs (EPS) more frequently than the other subtypes of ADCA [<xref ref-type="bibr" rid="B1">1</xref>]. Even within MJD, the EPS may vary, sometimes with marked dystonic postures, others with isolated parkinsonian features or even, though rarely, with the parkinsonian triad (resting tremor, bradykinesia and rigidity) [<xref ref-type="bibr" rid="B2">2</xref>]. Although the causative mutation of MJD is known to be an expansion of a CAG repeat motif (consensually more than 52 repeats) in the coding region of the <italic>ATXN3 </italic>gene [<xref ref-type="bibr" rid="B3">3</xref>], the size of the of the repetitive tract does not completely explain the clinical heterogeneity observed in this disorder, namely concerning the presence of EPS.</p>
      <p>There are only a few reports of a Parkinson's disease (PD)-like phenotype in molecularly confirmed MJD patients [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>], and thus this particular MJD phenotype remains poorly documented, namely from the genetic point of view. The cases reported in the literature showed an initial phenotype indistinguishable from PD and a levodopa positive response. Only after several years of progression the characteristic features of MJD, namely cerebellar signs, were observed. The parkinsonian phenotype has been suggested to be more common in MJD patients of African descent, although rare in those of European origin [<xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>MJD phenotypes with EPS, particularly those with a PD-like phenotype, may result from epistatic effects of variants in other loci. As primary candidates are PD associated loci, namely <italic>PARK2, LRRK2, PINK1, DJ-1, SNCA, MAPT</italic>, and <italic>APOE </italic>(e.g. [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>]). Variation in mitochondrial DNA (mtDNA) has also been shown to have an impact on neurodegenerative diseases' phenotype, and the <italic>tRNA</italic><sup><italic>Gln </italic></sup>T4336C mutation was previously associated with Alzheimer's disease (AD) and PD [<xref ref-type="bibr" rid="B11">11</xref>]. The main goal of this work was to describe two unrelated MJD patients displaying the parkinsonian triad, for which the genetic variation (mutations and/or polymorphisms) in PD associated loci was investigated.</p>
    </sec>
    <sec>
      <title>Case Presentation</title>
      <p>Out of a series of 70 molecularly confirmed MJD patients from the Azores Islands (Portugal), from whom DNA samples were available (extracted from blood samples, which were collected after obtaining written informed consent), two patients presenting the parkinsonian triad, and belonging to distinct MJD families (one from S&#xE3;o Miguel Island and other from Graciosa Island), were identified.</p>
      <sec>
        <title>Patient 1</title>
        <p>Patient 1 is a 40 year-old female patient (Figure <xref ref-type="fig" rid="F1">1</xref>; III-4). At the age of 30 years (Table <xref ref-type="table" rid="T1">1</xref>), she noticed slowness of movements. At examination, she had a poor mimic and marked bradykinesia. She responded well to L-dopa, which she maintained for 8 years. At this time she was hospitalized because of neurological aggravation and depression. She presented, besides a prominent parkinsonian syndrome with frequent on-off phenomena, cerebellar dysarthria and general incoordination, axial and upper limbs dystonia, upwards gaze limitation with upwards gaze nystagmus, generalized hyperreflexia and bilateral Babinski sign, as well as marked gait ataxia. Her mother (Figure <xref ref-type="fig" rid="F1">1</xref>; II-3) also had exhibited a parkinsonian phenotype. By the age of 34, she noticed difficulty in walking and in the fine movements of the hands. First examined at 36, she had bradykinesia, including amimia, bilateral hypertonia, without tremor, nor incoordination. The gait was purely parkinsonian, with small steps and no balance of the arms. She responded well to L-dopa, reaching a normal neurological examination under 300 mg + 75 mg of the inhibitor. Examined 12 years later, she was still under L-dopa treatment. Besides her parkinsonian syndrome and extreme diskynesias, she had a deep depression, a moderate gait and lower limbs' ataxia, cerebellar dysarthria, and marked upwards gaze limitation. The maternal grandfather of Patient 1 (Figure <xref ref-type="fig" rid="F1">1</xref>; I-1) had an onset at 63 years of age with slowly progressive gait ataxia, followed by dysarthria, diplopia and dysphagia. Examined the first time with 8 years of evolution, he had upwards gaze limitation and horizontal squint, moderate peroneal atrophy with generalized arreflexia, plantars in flexion, slight dysmetria in the upper limbs, marked dysmetria in the lower limbs and ataxic gait possible with unilateral support. Four years later mild Parkinson's signs were observed, with resting tremor in the upper limbs and bilateral rigidity. He died two years later aged 77 years.</p>
        <fig id="F1" position="float">
          <label>Figure 1</label>
          <caption>
            <p><bold>Pedigree of Patient 1.</bold> Black filled figures represent MJD patients; Crosshatched figures represent MJD patients with a parkinsonian phenotype.</p>
          </caption>
          <graphic xlink:href="1471-2377-11-131-1"/>
        </fig>
        <table-wrap id="T1" position="float">
          <label>Table 1</label>
          <caption>
            <p>Characteristics of Patient 1 and Patient 2</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left">Characteristics</th>
                <th align="center">Patient 1</th>
                <th align="center">Patient 2</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">
                  <bold>Age at Onset</bold>
                </td>
                <td align="center">30</td>
                <td align="center">33</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Onset Mode</bold>
                </td>
                <td align="center">Pure PD signs</td>
                <td align="center">PD plus cerebellar signs?</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>Family history for PD features</bold>
                </td>
                <td align="center">Mother and grandfather</td>
                <td align="center">NP</td>
              </tr>
              <tr>
                <td align="left">
                  <bold><italic>ATXN3 </italic>(CAG)n tract length</bold>
                </td>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;Normal Allele</td>
                <td align="center">14</td>
                <td align="center">29</td>
              </tr>
              <tr>
                <td align="left">&#x2003;Expanded Allele</td>
                <td align="center">72</td>
                <td align="center">72</td>
              </tr>
              <tr>
                <td align="left">
                  <bold><italic>PARK2 </italic>Gene Mutations</bold>
                </td>
                <td align="center">NP</td>
                <td align="center">NP</td>
              </tr>
              <tr>
                <td align="left">
                  <bold><italic>LRRK2 </italic>Gene Mutations</bold>
                </td>
                <td align="center">NP</td>
                <td align="center">NP</td>
              </tr>
              <tr>
                <td align="left">
                  <bold><italic>PINK1 </italic>Gene Mutations</bold>
                </td>
                <td align="center">NP</td>
                <td align="center">NP</td>
              </tr>
              <tr>
                <td align="left">
                  <bold><italic>DJ-1 </italic>Gene</bold>
                </td>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;<bold>Mutations</bold></td>
                <td align="center">NP</td>
                <td align="center">NP</td>
              </tr>
              <tr>
                <td align="left">&#x2003;<bold>Polymorphisms</bold></td>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;&#x2003;g.168_185del</td>
                <td align="center">Del/Del</td>
                <td align="center">Ins/Del</td>
              </tr>
              <tr>
                <td align="left">&#x2003;&#x2003;rs7517357</td>
                <td align="center">T/T</td>
                <td align="center">C/T</td>
              </tr>
              <tr>
                <td align="left">&#x2003;&#x2003;rs2641116</td>
                <td align="center">G/G</td>
                <td align="center">T/G</td>
              </tr>
              <tr>
                <td align="left">&#x2003;&#x2003;rs56327722</td>
                <td align="center">A/A</td>
                <td align="center">G/A</td>
              </tr>
              <tr>
                <td align="left">
                  <bold><italic>SNCA </italic>Gene</bold>
                </td>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;REP1</td>
                <td align="center">261/261</td>
                <td align="center">261/261</td>
              </tr>
              <tr>
                <td align="left">
                  <bold><italic>MAPT </italic>Gene</bold>
                </td>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;rs242557</td>
                <td align="center">A/G</td>
                <td align="center">G/G</td>
              </tr>
              <tr>
                <td align="left">&#x2003;Haplotype</td>
                <td align="center">H1/H2</td>
                <td align="center">H2/H2</td>
              </tr>
              <tr>
                <td align="left">
                  <bold><italic>APOE </italic>Gene</bold>
                </td>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;genotype</td>
                <td align="center">&#x3B5;2/&#x3B5;3</td>
                <td align="center">&#x3B5;2/&#x3B5;3</td>
              </tr>
              <tr>
                <td align="left">
                  <bold>mtDNA</bold>
                </td>
                <td/>
                <td/>
              </tr>
              <tr>
                <td align="left">&#x2003;T4336C mutation</td>
                <td align="center">NP</td>
                <td align="center">NP</td>
              </tr>
              <tr>
                <td align="left">&#x2003;Haplogroup</td>
                <td align="center">H</td>
                <td align="center">H</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>NP - Not present</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Patient 2</title>
        <p>Patient 2 is a 38 year-old male patient (Figure <xref ref-type="fig" rid="F2">2</xref>: II-16). He reported complaints of left hand's tremor since he was 33 years old. In neurological examination at the age of 35 years, he presented slight tremor of the left hand and of the L-lower limb. There was a cog-wheel rigidity of the left side, slight ataxia, hyperreflexia and right Babinski sign. The EPS responded consistently to L-dopa. His MRI was normal. His father (Figure <xref ref-type="fig" rid="F2">2</xref>: I-1) was only observed after 18 years of disease progression (reported onset at 42 years old), but did not present EPS. Furthermore, none of the remaining affected siblings (Figure <xref ref-type="fig" rid="F2">2</xref>: II-4, II-9, and II-12) present parkinsonian features.</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Pedigree of Patient 2.</bold> Black filled figures represent MJD patients; Crosshatched figures represent MJD patients with a parkinsonian phenotype.</p>
          </caption>
          <graphic xlink:href="1471-2377-11-131-2"/>
        </fig>
      </sec>
      <sec>
        <title>Molecular analysis</title>
        <p>The <italic>ATXN3 </italic>(CAG)<sub>n </sub>tract size was determined as previously described [<xref ref-type="bibr" rid="B12">12</xref>]. All the exons and exon-introns boundaries of <italic>PARK2, LRRK2, PINK1 </italic>and <italic>DJ-1 </italic>genes were amplified by PCR. The resulting PCR products were purified by Exo-SAP treatment (GE Healthcare) and sequenced using the BigDye<sup>&#xAE; </sup>Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). Multiplex Ligation-Dependent Probe Amplification (MLPA) was used, according to Djarmati <italic>et al</italic>. [<xref ref-type="bibr" rid="B13">13</xref>], to search for large deletions or duplications in <italic>PARK2, PINK1 </italic>and <italic>DJ-1</italic>. The <italic>SNCA </italic>REP1 allele-length variants were genotyped as previously described [<xref ref-type="bibr" rid="B9">9</xref>]. In <italic>MAPT </italic>locus, a SNP (rs242557) was genotyped by a custom Taqman assay according to the manufacturer's specifications, and its genotype was used to infer <italic>MAPT </italic>haplotypes. The <italic>APOE </italic>genotypes were determined according to Bettencourt <italic>et al</italic>. [<xref ref-type="bibr" rid="B14">14</xref>]. The mtDNA haplogroup was established as previously described by Santos <italic>et al</italic>. [<xref ref-type="bibr" rid="B15">15</xref>], and the region encompassing the T4336C mutation was amplified by PCR, according to Ramos <italic>et al</italic>. [<xref ref-type="bibr" rid="B16">16</xref>]. PCR products were purified using the JETQUICK PCR Purification Spin Kit (Genomed) and sequenced, using the BigDye<sup>&#xAE; </sup>Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems), according to the manufacturer's specifications.</p>
        <p>Both patients presented 72 CAG repeats in their expanded <italic>ATXN3 </italic>allele (Table <xref ref-type="table" rid="T1">1</xref>), which corresponds to the mode for the expanded alleles in the Azorean MJD series [<xref ref-type="bibr" rid="B17">17</xref>]. In <italic>PARK2, LRRK2, PINK1, DJ-1 </italic>and mtDNA <italic>tRNA</italic><sup><italic>Gln</italic></sup>, no known pathogenic mutations were detected in the analyzed regions (Table <xref ref-type="table" rid="T1">1</xref>). Several polymorphisms were found at the <italic>DJ-1 </italic>gene (Table <xref ref-type="table" rid="T1">1</xref>). Results for the <italic>SNCA </italic>REP1, <italic>MAPT </italic>and <italic>APOE </italic>loci, as well as for the mtDNA haplogroup, are shown in Table <xref ref-type="table" rid="T1">1</xref>.</p>
        <p>Although MJD presents EPS more frequently than the other ADCAs, the manifestation of the parkinsonian triad is rare, being present in less than 3% of the analyzed MJD series. Even though the two studied cases are distinct, the grandfather-mother-daughter transmission in the family of Patient 1, and the heterogeneity presented by the family of Patient 2, suggests a supporting genetic background, e.g. modifier gene(s).</p>
        <p>Mutations in the <italic>PARK2 </italic>gene have been described as the most frequent in the cases of early onset PD [<xref ref-type="bibr" rid="B18">18</xref>]. However, none of the studied patients presented mutations in this gene. Similarly, no mutations were identified in <italic>LRRK2, PINK1 </italic>and <italic>DJ-1 </italic>genes, or in position 4336 of mtDNA.</p>
        <p>Given the fact that both patients belong to a typically European mtDNA haplogroup [<xref ref-type="bibr" rid="B15">15</xref>], the hypothesis of an African background, in which the parkinsonian phenotype seems more common [<xref ref-type="bibr" rid="B7">7</xref>], was not supported, at least in terms of maternal origin.</p>
        <p>Association studies have shown that certain alleles of the <italic>SNCA </italic>REP1 locus, as well as the presence of two copies of <italic>MAPT </italic>H1, increase the risk of PD (e.g. [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]). In the patients analyzed, however, the homozygousity for the 261 allele (the commonest among Caucasians [<xref ref-type="bibr" rid="B9">9</xref>]), and the presence of at least one <italic>MAPT </italic>H2 was confirmed.</p>
        <p>Although previous studies [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>] failed to find an association between <italic>DJ-1 </italic>g.168_185del polymorphism and PD, De Marco <italic>et al</italic>. [<xref ref-type="bibr" rid="B21">21</xref>], using a larger series of PD patients, have reported that several <italic>DJ-1 </italic>polymorphisms, including those observed in the present study and reported in Table <xref ref-type="table" rid="T1">1</xref>, are significantly associated with PD.</p>
        <p>The <italic>APOE </italic>&#x3B5;2 has been associated with increased risk of sporadic PD [<xref ref-type="bibr" rid="B8">8</xref>], and with an earlier onset of PD (e.g. [<xref ref-type="bibr" rid="B22">22</xref>]). The studied patients presented both the <italic>APOE </italic>&#x3B5;2/&#x3B5;3 genotype.</p>
        <p>In non-Parkinsonian patients (N = 55) from the Azorean MJD series (data not shown), the <italic>DJ-1 </italic>g.168_185del was found in 23% of the alleles, not differing from the frequency of this deletion in other non-Parkinsonian Caucasian populations studied previously (e.g. [<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B21">21</xref>]). The <italic>APOE </italic>&#x3B5;2 allele was present in only 4% of the alleles, which corresponds to a lower frequency than the one previously reported for this allele in the general Azorean population [<xref ref-type="bibr" rid="B14">14</xref>]. Besides the two Parkinsonian MJD patients studied here, only 2 additional Azorean patients (non-Parkinsonian) carry both the <italic>DJ-1 </italic>g.168_185del and the <italic>APOE </italic>&#x3B5;2 allele.</p>
      </sec>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>The present report, in these two MJD patients, adds information on this rare phenotype, by allowing a deeper knowledge of the clinical and genetic variation present in such particular cases. Analysis of both pedigrees supports a genetic background influence. Although we cannot conclude on the presence of associations by studying only two Parkinsonian patients, the present results are in agreement with previous studies on Parkinson's disease. The implication of these findings, on what concerns a possible epistatic effect of the <italic>DJ-1 </italic>g.168_185del and the <italic>APOE </italic>&#x3B5;2 allele on the MJD phenotype deserves to be tested, using an appropriate study design, namely on what concerns adequate sized parkinsonian MJD series (presently unavailable, to our knowledge).</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written consent was obtained from both patients for the publication of this case report. A copy of written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>CB participated in the design of the study, carried out part of the molecular analysis and drafted the manuscript. CS, PR, TC, and MR participated in the molecular analysis. PC have collected part of the clinical data and contributed to draft the manuscript. TK and JV were involved in the sampling process and in the collection of the clinical data. PH participated in the design and discussion of the study. ML participated in the design and coordination of the study, and helped to draft the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2377/11/131/prepub">http://www.biomedcentral.com/1471-2377/11/131/prepub</ext-link>
      </p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgements</title>
      <p>This work was supported by "PRI-DMJ" (funded by Regional Government of the Azores), and "Transcriptional variation of the <italic>ATXN3 </italic>gene as modulator of the clinical heterogeneity in Machado-Joseph disease (MJD)" (PIC/IC/83074/2007, funded by "Funda&#xE7;&#xE3;o para a Ci&#xEA;ncia e a Tecnologia" - FCT). C.B. [SFRH/BPD/63121/2009] and T.C. [SFRH/BPD/38659/2007] are postdoctoral fellows from FCT.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Schols</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Peters</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Szymanski</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kruger</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lange</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hardt</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Riess</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Przuntek</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Extrapyramidal motor signs in degenerative ataxias</article-title>
          <source>Arch Neurol</source>
          <year>2000</year>
          <volume>57</volume>
          <issue>10</issue>
          <fpage>1495</fpage>
          <lpage>1500</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.57.10.1495</pub-id>
          <pub-id pub-id-type="pmid">11030803</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="book">
          <name>
            <surname>Coutinho</surname>
            <given-names>P</given-names>
          </name>
          <source>Doen&#xE7;a de Machado-Joseph: Tentativa de defini&#xE7;&#xE3;o</source>
          <year>1992</year>
          <publisher-name>PhD Dissertation, Instituto de Ci&#xEA;ncias Biom&#xE9;dicas Abel Salazar, Porto</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bettencourt</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lima</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Machado-Joseph Disease: from first descriptions to new perspectives</article-title>
          <source>Orphanet J Rare Dis</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>35</fpage>
          <pub-id pub-id-type="doi">10.1186/1750-1172-6-35</pub-id>
          <pub-id pub-id-type="pmid">21635785</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tuite</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Rogaeva</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>St George-Hyslop</surname>
            <given-names>PH</given-names>
          </name>
          <name>
            <surname>Lang</surname>
            <given-names>AE</given-names>
          </name>
          <article-title>Dopa-responsive parkinsonism phenotype of Machado-Joseph disease: confirmation of 14q CAG expansion</article-title>
          <source>Ann Neurol</source>
          <year>1995</year>
          <volume>38</volume>
          <issue>4</issue>
          <fpage>684</fpage>
          <lpage>687</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.410380422</pub-id>
          <pub-id pub-id-type="pmid">7574470</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Gwinn-Hardy</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Singleton</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>O'Suilleabhain</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Boss</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nicholl</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Adam</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hussey</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Critchley</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hardy</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Farrer</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family</article-title>
          <source>Arch Neurol</source>
          <year>2001</year>
          <volume>58</volume>
          <issue>2</issue>
          <fpage>296</fpage>
          <lpage>299</lpage>
          <pub-id pub-id-type="doi">10.1001/archneur.58.2.296</pub-id>
          <pub-id pub-id-type="pmid">11176969</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Buhmann</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bussopulos</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Oechsner</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Dopaminergic response in Parkinsonian phenotype of Machado-Joseph disease</article-title>
          <source>Mov Disord</source>
          <year>2003</year>
          <volume>18</volume>
          <issue>2</issue>
          <fpage>219</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="doi">10.1002/mds.10322</pub-id>
          <pub-id pub-id-type="pmid">12539220</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Subramony</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Hernandez</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Adam</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Smith-Jefferson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hussey</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gwinn-Hardy</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Lynch</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>McDaniel</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Hardy</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Farrer</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
          <article-title>Ethnic differences in the expression of neurodegenerative disease: Machado-Joseph disease in Africans and Caucasians</article-title>
          <source>Mov Disord</source>
          <year>2002</year>
          <volume>17</volume>
          <issue>5</issue>
          <fpage>1068</fpage>
          <lpage>1071</lpage>
          <pub-id pub-id-type="doi">10.1002/mds.10241</pub-id>
          <pub-id pub-id-type="pmid">12360561</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Huang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Poole</surname>
            <given-names>C</given-names>
          </name>
          <article-title>APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease</article-title>
          <source>Neurology</source>
          <year>2004</year>
          <volume>62</volume>
          <issue>12</issue>
          <fpage>2198</fpage>
          <lpage>2202</lpage>
          <pub-id pub-id-type="pmid">15210882</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Maraganore</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>de Andrade</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Elbaz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Farrer</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Ioannidis</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Kruger</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Rocca</surname>
            <given-names>WA</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>NK</given-names>
          </name>
          <name>
            <surname>Lesnick</surname>
            <given-names>TG</given-names>
          </name>
          <name>
            <surname>Lincoln</surname>
            <given-names>SJ</given-names>
          </name>
          <etal/>
          <article-title>Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease</article-title>
          <source>JAMA</source>
          <year>2006</year>
          <volume>296</volume>
          <issue>6</issue>
          <fpage>661</fpage>
          <lpage>670</lpage>
          <pub-id pub-id-type="doi">10.1001/jama.296.6.661</pub-id>
          <pub-id pub-id-type="pmid">16896109</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Wider</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wszolek</surname>
            <given-names>ZK</given-names>
          </name>
          <article-title>Clinical genetics of Parkinson's disease and related disorders</article-title>
          <source>Parkinsonism Relat Disord</source>
          <year>2007</year>
          <volume>13 Suppl 3</volume>
          <fpage>S229</fpage>
          <lpage>232</lpage>
          <pub-id pub-id-type="pmid">18267241</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shoffner</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Torroni</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lott</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Cabell</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Mirra</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Beal</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Gearing</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Salvo</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
          <article-title>Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients</article-title>
          <source>Genomics</source>
          <year>1993</year>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>171</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="doi">10.1006/geno.1993.1299</pub-id>
          <pub-id pub-id-type="pmid">8104867</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bettencourt</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fialho</surname>
            <given-names>RN</given-names>
          </name>
          <name>
            <surname>Santos</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Montiel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bruges-Armas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Maciel</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lima</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal)</article-title>
          <source>J Hum Genet</source>
          <year>2008</year>
          <volume>53</volume>
          <issue>4</issue>
          <fpage>333</fpage>
          <lpage>339</lpage>
          <pub-id pub-id-type="doi">10.1007/s10038-008-0261-7</pub-id>
          <pub-id pub-id-type="pmid">18286225</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Djarmati</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Guzvic</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Grunewald</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lang</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Pramstaller</surname>
            <given-names>PP</given-names>
          </name>
          <name>
            <surname>Simon</surname>
            <given-names>DK</given-names>
          </name>
          <name>
            <surname>Kaindl</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Vieregge</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Nygren</surname>
            <given-names>AO</given-names>
          </name>
          <name>
            <surname>Beetz</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
          <article-title>Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification</article-title>
          <source>Mov Disord</source>
          <year>2007</year>
          <volume>22</volume>
          <issue>12</issue>
          <fpage>1708</fpage>
          <lpage>1714</lpage>
          <pub-id pub-id-type="doi">10.1002/mds.21370</pub-id>
          <pub-id pub-id-type="pmid">17674414</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bettencourt</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Montiel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Santos</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Pavao</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Viegas-Crespo</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Lopes</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Lima</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Polymorphism of the APOE locus in the Azores Islands (Portugal)</article-title>
          <source>Hum Biol</source>
          <year>2006</year>
          <volume>78</volume>
          <issue>4</issue>
          <fpage>509</fpage>
          <lpage>512</lpage>
          <pub-id pub-id-type="doi">10.1353/hub.2006.0053</pub-id>
          <pub-id pub-id-type="pmid">17278624</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Santos</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lima</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Montiel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Angles</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pires</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Abade</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Aluja</surname>
            <given-names>MP</given-names>
          </name>
          <article-title>Genetic structure and origin of peopling in the Azores islands (Portugal): the view from mtDNA</article-title>
          <source>Ann Hum Genet</source>
          <year>2003</year>
          <volume>67</volume>
          <issue>Pt 5</issue>
          <fpage>433</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="pmid">12940917</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ramos</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Santos</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Alvarez</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Nogues</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Aluja</surname>
            <given-names>MP</given-names>
          </name>
          <article-title>Human mitochondrial DNA complete amplification and sequencing: a new validated primer set that prevents nuclear DNA sequences of mitochondrial origin co-amplification</article-title>
          <source>Electrophoresis</source>
          <year>2009</year>
          <volume>30</volume>
          <issue>9</issue>
          <fpage>1587</fpage>
          <lpage>1593</lpage>
          <pub-id pub-id-type="doi">10.1002/elps.200800601</pub-id>
          <pub-id pub-id-type="pmid">19350543</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bettencourt</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Santos</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Montiel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kay</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vasconcelos</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Maciel</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lima</surname>
            <given-names>M</given-names>
          </name>
          <article-title>The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls</article-title>
          <source>Eur J Hum Genet</source>
          <year>2010</year>
          <volume>18</volume>
          <issue>5</issue>
          <fpage>621</fpage>
          <lpage>623</lpage>
          <pub-id pub-id-type="doi">10.1038/ejhg.2009.215</pub-id>
          <pub-id pub-id-type="pmid">19935829</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Macedo</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Verbaan</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Fang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>van Rooden</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Visser</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Anar</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Uras</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Groen</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Rizzu</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>van Hilten</surname>
            <given-names>JJ</given-names>
          </name>
          <etal/>
          <article-title>Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease</article-title>
          <source>Mov Disord</source>
          <year>2009</year>
          <volume>24</volume>
          <issue>2</issue>
          <fpage>196</fpage>
          <lpage>203</lpage>
          <pub-id pub-id-type="doi">10.1002/mds.22287</pub-id>
          <pub-id pub-id-type="pmid">18973254</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Eerola</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hernandez</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Launes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hellstrom</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Hague</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gulick</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Peuralinna</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hardy</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tienari</surname>
            <given-names>PJ</given-names>
          </name>
          <etal/>
          <article-title>Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD</article-title>
          <source>Neurology</source>
          <year>2003</year>
          <volume>61</volume>
          <issue>7</issue>
          <fpage>1000</fpage>
          <lpage>1002</lpage>
          <pub-id pub-id-type="pmid">14557580</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Morris</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>O'Brien</surname>
            <given-names>KK</given-names>
          </name>
          <name>
            <surname>Gibson</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Hardy</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Singleton</surname>
            <given-names>AB</given-names>
          </name>
          <article-title>Polymorphism in the human DJ-1 gene is not associated with sporadic dementia with Lewy bodies or Parkinson's disease</article-title>
          <source>Neurosci Lett</source>
          <year>2003</year>
          <volume>352</volume>
          <issue>2</issue>
          <fpage>151</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neulet.2003.08.037</pub-id>
          <pub-id pub-id-type="pmid">14625045</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>De Marco</surname>
            <given-names>EV</given-names>
          </name>
          <name>
            <surname>Annesi</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tarantino</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Nicoletti</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Civitelli</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Messina</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Annesi</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Arabia</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Salsone</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Condino</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
          <article-title>DJ-1 is a Parkinson's disease susceptibility gene in southern Italy</article-title>
          <source>Clin Genet</source>
          <year>2010</year>
          <volume>77</volume>
          <issue>2</issue>
          <fpage>183</fpage>
          <lpage>188</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1399-0004.2009.01310.x</pub-id>
          <pub-id pub-id-type="pmid">19968671</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Zareparsi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Camicioli</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sexton</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bird</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Swanson</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kaye</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nutt</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Payami</surname>
            <given-names>H</given-names>
          </name>
          <article-title>Age at onset of Parkinson disease and apolipoprotein E genotypes</article-title>
          <source>Am J Med Genet</source>
          <year>2002</year>
          <volume>107</volume>
          <issue>2</issue>
          <fpage>156</fpage>
          <lpage>161</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.10111</pub-id>
          <pub-id pub-id-type="pmid">11807891</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
